series-c-plus
Stage
1
Investors
About
Field Trip develops and delivers psychedelic-assisted therapies and advanced biological treatments such as ketamine programs and Stellate Ganglion Block (SGB) to support mental health conditions including anxiety, depression, and PTSD.
Explore Field Trip's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.